SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000919574-12-000171
Filing Date
2012-01-13
Accepted
2012-01-13 14:33:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 d1257259_13d-a.htm SC 13D/A 199330
  Complete submission text file 0000919574-12-000171.txt   201123
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1226
Type: SC 13D/A | Act: 34 | File No.: 005-31596 | Film No.: 12526314
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 595 MADISON AVENUE 17TH FLOOR NEW YORK NY 10022
Business Address 595 MADISON AVENUE 17TH FLOOR NEW YORK NY 10022 212-554-2390
683 Capital Management, LLC (Filed by) CIK: 0001404574 (see all company filings)

IRS No.: 205100992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A